-+ 0.00%
-+ 0.00%
-+ 0.00%

Canaccord Genuity Maintains Buy on Privia Health Gr, Lowers Price Target to $34

Benzinga·05/08/2026 22:34:10
Listen to the news
Canaccord Genuity analyst Richard Close maintains Privia Health Gr (NASDAQ:PRVA) with a Buy and lowers the price target from $35 to $34.